sponsored
PatientsVille.com Logo

PatientsVille

Somatropin Craniopharyngioma Side Effects

Somatropin Craniopharyngioma Side Effect Reports


The following Somatropin Craniopharyngioma side effect reports were submitted by healthcare professionals and consumers.

This information will help you understand how side effects, such as Craniopharyngioma, can occur, and what you can do about them.

A side effect could appear soon after you start Somatropin or it might take time to develop.



Craniopharyngioma, Injection Site Bruising

This Craniopharyngioma side effect was reported by a health professional from GB. A patient (weight:NA) experienced the following symptoms/conditions: hypopituitarism. The patient was prescribed Somatropin (dosage: 1 Unk, Unk), which was started on Apr 10, 2013. Concurrently used drugs: NA. When starting to take Somatropin the consumer reported the following symptoms:
  • Craniopharyngioma
  • Injection Site Bruising
These side effects may potentially be related to Somatropin.
Craniopharyngioma

This Craniopharyngioma Somatropin side effect was reported by a consumer or non-health professional from ES on Apr 25, 2013. A male , child 6 years of age, was diagnosed with and was treated with Somatropin. The patient presented the following health conditions:
  • Craniopharyngioma
. Somatropin dosage: Unk. Additional drugs used at the same time: NA.
Craniopharyngioma, Neoplasm Recurrence

This is a Somatropin side effect report of a 11-year-old patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Somatropin (dosage:0.8 Mg, 1x/day, start time: Jan 22, 2009), combined with: NA., and developed a serious reaction and a Craniopharyngioma side effect. The patient presented with:
  • Craniopharyngioma
  • Neoplasm Recurrence
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Somatropin treatment in patients suffering from NA, resulting in Craniopharyngioma.

Neoplasm Recurrence, Craniopharyngioma

A 11-year-old patient (weight: NA) from JAPAN with the following symptoms: NA started Somatropin treatment (dosage: 0.8 Mg, 1x/day) on Jul 16, 2009. Soon after starting Somatropin treatment, the consumer experienced several side effects, including:
  • Neoplasm Recurrence
  • Craniopharyngioma
. Concurrently used drugs:
  • Gonadotropin Chorionic (900 Iu, Monthly)
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Somatropin side effects, such as Craniopharyngioma.
Craniopharyngioma

A patient from FR was prescribed and started Somatropin on Nov 15, 2012. Patient felt the following Somatropin side effects: craniopharyngioma Additional patient health information: male , 35 years of age, The consumer reported the following symptoms: was diagnosed with and. Somatropin dosage: NA. Concurrently used drugs: NA. The patient was hospitalized.
Craniopharyngioma, Neoplasm Recurrence

This report suggests a potential Somatropin Craniopharyngioma side effect(s) that can have serious consequences. A 11-year-old patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): NA and used Somatropin (dosage: 0.8 Mg, 1x/day) starting Nov 11, 2010. Soon after starting Somatropin the patient began experiencing various side effects, including:
  • Craniopharyngioma
  • Neoplasm Recurrence
Drugs used concurrently:NA. The patient was hospitalized. Although Somatropin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Craniopharyngioma, may still occur.
Craniopharyngioma, Condition Aggravated

An adverse event was reported by a physician on Apr 19, 2012 by a Female taking Somatropin (dosage: 0.2 Mg, 1x/day) was diagnosed with and. Location: FRANCE , 51 years of age, weighting 147.7 lb, patient began experiencing various side effects, including: Directly after treatment started, patient experienced the unwanted or unexpected Somatropin side effects: craniopharyngioma, condition aggravated. Additional medications/treatments:
Associated medications used:
  • Levothyroxine Sodium
  • Ixel (Unk)
  • Ixel
  • Minirin ^aventis Pharma^ (Unk)
  • Prazepam (1 Df, 1x/day)
The patient was hospitalized.
Craniopharyngioma, Neoplasm Recurrence

This Craniopharyngioma problem was reported by a health professional from SPAIN. A 22-year-old patient (weight: NA) was diagnosed with the following medical condition(s): growth hormone deficiency,blood antidiuretic hormone decreased,blood luteinising hormone decreased,primary hypothyroidism,blood corticotrophin decreased,blood thyroid stimulating hormone decreased,blood follicle stimulating hormone decreased,hypogonadism.On Jan 24, 2008 a consumer started treatment with Somatropin (dosage: 1 Mg, Daily). The following drugs/medications were being taken at the same time:
  • Desmopressin (Unk)
  • Testosterone
  • Thyroxine ^aps^ (Unk)
  • Hidroaltesona (Unk)
  • Thyroxine ^aps^
  • Testosterone (Unk)
  • Testosterone
When commencing Somatropin, the patient experienced the following unwanted symptoms /side effects:
  • Craniopharyngioma
  • Neoplasm Recurrence
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Craniopharyngioma, may become evident only after a product is in use by the general population.
Craniopharyngioma, Condition Aggravated, Visual Impairment

This is a Somatropin side effect report of a 45-year-old female patient (weight: NA) from AUSTRIA. The patient developed the following symptoms/conditions: hypopituitarism and was treated with Somatropin (dosage: Unk) starting Jun 09, 2004. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Craniopharyngioma
  • Condition Aggravated
  • Visual Impairment
The patient was hospitalized. This opens a possibility that Somatropin could cause Craniopharyngioma and that some female patients may be more susceptible.
Craniopharyngioma, Neoplasm Progression

This Craniopharyngioma side effect was reported by a health professional from UNITED KINGDOM on Nov 15, 2011. A patient from UNITED KINGDOM , 45 years of age, weighting 202.8 lb, was diagnosed with and was treated with Somatropin. Directly after treatment started, patient experienced the unwanted or unexpected Somatropin side effects: craniopharyngioma, neoplasm progression. Somatropin dosage: 0.2 Mg, 1x/day.
Associated medications used:
  • Testosterone (1000 Mg, Unk)
  • Ddavp (200 Ug, Unk)
These side effects may potentially be related to Somatropin.
Craniopharyngioma, Neoplasm Recurrence

This Craniopharyngioma side effect was reported by a physician from SLOVAKIA (Slovak Republic). A 35-year-old patient (weight:NA) experienced the following symptoms/conditions: growth hormone deficiency. The patient was prescribed Somatropin Rdna (dosage: 0.2 Mg, 1x/day), which was started on Oct 28, 2009. Concurrently used drugs: NA. When starting to take Somatropin Rdna the consumer reported the following symptoms:
  • Craniopharyngioma
  • Neoplasm Recurrence
The patient was hospitalized. These side effects may potentially be related to Somatropin Rdna.
Craniopharyngioma, Disease Progression

This Craniopharyngioma Somatropin side effect was reported by a physician from GERMANY on Jul 04, 2011. A male , child 4 years of age, weighting 50.71 lb, was diagnosed with and was treated with Somatropin. The patient presented the following health conditions:
  • Craniopharyngioma
  • Disease Progression
. Somatropin dosage: 0.5 Mg, 1x/day. Additional drugs used at the same time:
  • Hydrocortisone (5mg/2.5mg/2.5mg Daily)
  • Levothyroxine Sodium (62.5 Ug, Unk)
  • Minrin (Unk, As Needed)
The patient was hospitalized.
Craniopharyngioma, Neoplasm Recurrence

This is a Somatropin side effect report of a 13-year-old patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: hypopituitarism, who was treated with Somatropin (dosage:0.8 Mg, 1x/day, start time: Nov 15, 2004), combined with: NA., and developed a serious reaction and a Craniopharyngioma side effect. The patient presented with:
  • Craniopharyngioma
  • Neoplasm Recurrence
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Somatropin treatment in patients suffering from hypopituitarism, resulting in Craniopharyngioma.
Neoplasm Recurrence, Craniopharyngioma

A 10-year-old patient (weight: NA) from JAPAN with the following symptoms: growth hormone deficiency started Somatropin treatment (dosage: 0.025 Mg/kg/day) on NS. Soon after starting Somatropin treatment, the consumer experienced several side effects, including:
  • Neoplasm Recurrence
  • Craniopharyngioma
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Somatropin side effects, such as Craniopharyngioma.
Neoplasm Recurrence, Craniopharyngioma

A patient from JAPAN was prescribed and started Somatropin on Apr 11, 2011. After Somatropin was administered, patient encountered several Somatropin side effects: neoplasm recurrence, craniopharyngioma Additional patient health information: male , child 10 years of age, The consumer reported the following symptoms: was diagnosed with and. Somatropin dosage: 0.025 Mg/kg/day. Concurrently used drugs: NA.
Craniopharyngioma

This report suggests a potential Somatropin Craniopharyngioma side effect(s) that can have serious consequences. A female patient from UNITED KINGDOM (weight:NA) was diagnosed with the following health condition(s): hypopituitarism and used Somatropin (dosage: 1.8 Mg, Qd) starting May 24, 2006. Soon after starting Somatropin the patient began experiencing various side effects, including:
  • Craniopharyngioma
Drugs used concurrently:
  • Levothyrox (200 A?g, Qd)
Although Somatropin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Craniopharyngioma, may still occur.
Craniopharyngioma

An adverse event was reported by a physician on Dec 10, 2010 by a Female taking Somatropin Rdna (dosage: 1.6 Mg, 6/week) was diagnosed with and. Location: UNITED KINGDOM , weighting 93.92 lb, patient began experiencing various side effects, including: Patient felt the following Somatropin side effects: craniopharyngioma. Additional medications/treatments:
Craniopharyngioma, Neoplasm Recurrence

This Craniopharyngioma problem was reported by a physician from GERMANY. A 45-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): hypopituitarism.On Sep 01, 2008 a consumer started treatment with Somatropin (dosage: 0.2 Mg, 1x/day). The following drugs/medications were being taken at the same time: NA. When commencing Somatropin, the patient experienced the following unwanted symptoms /side effects:
  • Craniopharyngioma
  • Neoplasm Recurrence
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Craniopharyngioma, may become evident only after a product is in use by the general population.
Craniopharyngioma, Neoplasm Recurrence

This is a Somatropin side effect report of a 45-year-old female patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: hypopituitarism and was treated with Somatropin (dosage: 0.1 Mg, 1x/day) starting Sep 01, 2008. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Craniopharyngioma
  • Neoplasm Recurrence
The patient was hospitalized. This opens a possibility that Somatropin could cause Craniopharyngioma and that some female patients may be more susceptible.
Craniopharyngioma, Disease Progression

This Craniopharyngioma side effect was reported by a physician from GERMANY on Nov 05, 2010. A patient from GERMANY , child 4 years of age, weighting 50.71 lb, was diagnosed with and was treated with Somatropin. Patient felt the following Somatropin side effects: craniopharyngioma, disease progression. Somatropin dosage: 0.5 Mg, 1x/day. The patient was hospitalized. These side effects may potentially be related to Somatropin.
1 of 2 

DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Somatropin Craniopharyngioma Causes and Reviews


Your pituitary gland is a pea-sized gland at the base of your brain. The pituitary is the "master control gland" - it makes hormones that affect growth and the functions of other glands in the body.

Pituitary tumors are common, but often they don't cause health problems. Most people with pituitary tumors never even know they have them. The most common type of pituitary tumor produces hormones and disrupts the balance of hormones in your body. This can cause endocrine diseases such as Cushing's syndrome and hyperthyroidism.

Symptoms of pituitary tumors include

  • Headaches
  • Vision problems
  • Nausea and vomiting
  • Problems caused by the production of too many hormones

Pituitary tumors are usually curable. Treatment is often surgery to remove the tumor. Other options include medicines, radiation therapy, and chemotherapy.


Somatropin Craniopharyngioma Reviews

Fri, 24 Feb 2012

My 19 year old son tried to give blood the other day and he was refused because he answered the question that he had taken HGH, Somatropin under a doctor's care.  He asked why and they said it had been shown to cause birth defects.  I am trying to find information on that but I am not being successful.
He took the drugs for about 5 years 12-17.  As we look to the future and him possibly having children is this something we need to be concerned about or aware of?  We are in the process of contacting the doctor who prescribed the meds to get his input.

Tue, 19 Jul 2011

Why do people die after starting Growth Hormone treatment?

Fri, 08 Jul 2011

Sorry about my poor medical english.
I am counselling as a lawyer a young man suffering from liposarcoma, we believe related to Saizen that he received during his childhood.Saizen was the french commercial name for Somatropin.
Has anyone got info on the related risk of cancer?
I would very much appreciate any help to links or info.

Mon, 19 Oct 2009
at what age will be recomended to use HGH for athlete of high level of competence..
Tue, 11 Jan 2011
I've been on it for 9 months. I weighed at the beginning 125 and had a body fat of 24. I now weigh 130 I have the same body fat percentage. While I have increased muscle mass, I eat well work out, have increased cardio amp; workouts, I'm sad that the only way that I can decrease my body fat is to eat less amp; be hungry always. So of course I can get leaner but cannot stay there. Too painful. It has increased my recovery time from workouts but I'm thinking of going off of it since I am able to control my weight the same as with it or without it.. I am wondering if others do not get leaned out on his product.. I started it because I was so deficient that I had to recover for weeks most time between workouts and had trouble functioning in my. Life. So that is superior now. I thought it would help with fat loss but it does not for me
Sat, 09 Jul 2011
hi i need information toward Somatropin label price?
DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Common Drugs

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Top Somatropin Side Effects

Craniopharyngioma (59)
Death (54)
Pituitary Tumour Benign (45)
Neoplasm Recurrence (43)
Condition Aggravated (42)
Sleep Apnoea Syndrome (41)
Adenoidal Hypertrophy (33)
Meningioma (29)
Tonsillar Hypertrophy (28)
Headache (27)
Prostate Cancer (23)
Dyspnoea (22)
Germ Cell Cancer (20)
Fall (20)
Scoliosis (19)
Convulsion (18)
Pneumonia (18)
Vomiting (18)
Disease Progression (17)
Osteochondrosis (16)
Abdominal Pain (15)
Osteonecrosis (15)
Brain Neoplasm (15)
Neoplasm Progression (15)
Fatigue (14)
Diabetes Mellitus (14)
Arthralgia (14)
Cardiac Arrest (14)
Asthenia (13)
Astrocytoma (12)
Cerebrovascular Accident (12)
Hypertension (12)
Papillary Thyroid Cancer (12)
Nausea (12)
Fracture (11)
Dysphonia (11)
Epiphysiolysis (11)
Hemiparesis (11)
Tachyarrhythmia (11)
Sudden Death (11)
Laryngocele (10)
Hepatic Function Abnormal (10)
Brain Neoplasm Malignant (10)
Medulloblastoma Recurrent (10)
Gastroenteritis (10)
Renal Cell Carcinoma (10)
Stridor (10)
Somnolence (10)
Respiratory Distress (10)
Pituitary Tumour Recurrent (10)

➢ More

Discuss Somatropin Side Effects